OBJECTIVES: We investigated whether local abciximab delivery to the site of intracoronary thrombus is more effective than intracoronary bolus infusion in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention and downstream clopidogrel administration. BACKGROUND: The intracoronary route of administration does not allow an optimal contact between the plaque components and abciximab, which is rapidly washed out by the coronary flow. METHODS: A total of 50 patients with ACS and a significant lesion in the culprit artery indicative of local thrombosis were randomly assigned to receive local intracoronary delivery of abciximab through a dedicated perfusion catheter or intracoronary infusion through the guiding catheter. The primary end point was the change in thrombus score after angioplasty by optical coherence tomography. RESULTS: After the intervention, the mean percentage change of the thrombus score was significantly higher among patients of the local delivery group compared with those of the intracoronary infusion group (33.8% vs. 3.9%, p = 0.002). Post-procedural corrected Thrombolysis in Myocardial Infarction frame count was shorter in the local delivery group compared with the intracoronary infusion group (15.3 ± 10.2 vs. 21.1 ± 9.9, p = 0.049). Procedure-related myocardial infarction was observed in 10% and 43% of patients in the local delivery and intracoronary infusion groups, respectively (p = 0.018). At 1 year, MACE were observed in 5.9% and 27.2% of patients in the local delivery and intracoronary infusion groups, respectively (p = 0.046). CONCLUSIONS: Local intracoronary delivery of abciximab by means of a dedicated perfusion catheter reduces thrombus burden with the potential to improve coronary microcirculation.
RCT Entities:
OBJECTIVES: We investigated whether local abciximab delivery to the site of intracoronary thrombus is more effective than intracoronary bolus infusion in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention and downstream clopidogrel administration. BACKGROUND: The intracoronary route of administration does not allow an optimal contact between the plaque components and abciximab, which is rapidly washed out by the coronary flow. METHODS: A total of 50 patients with ACS and a significant lesion in the culprit artery indicative of local thrombosis were randomly assigned to receive local intracoronary delivery of abciximab through a dedicated perfusion catheter or intracoronary infusion through the guiding catheter. The primary end point was the change in thrombus score after angioplasty by optical coherence tomography. RESULTS: After the intervention, the mean percentage change of the thrombus score was significantly higher among patients of the local delivery group compared with those of the intracoronary infusion group (33.8% vs. 3.9%, p = 0.002). Post-procedural corrected Thrombolysis in Myocardial Infarction frame count was shorter in the local delivery group compared with the intracoronary infusion group (15.3 ± 10.2 vs. 21.1 ± 9.9, p = 0.049). Procedure-related myocardial infarction was observed in 10% and 43% of patients in the local delivery and intracoronary infusion groups, respectively (p = 0.018). At 1 year, MACE were observed in 5.9% and 27.2% of patients in the local delivery and intracoronary infusion groups, respectively (p = 0.046). CONCLUSIONS: Local intracoronary delivery of abciximab by means of a dedicated perfusion catheter reduces thrombus burden with the potential to improve coronary microcirculation.
Authors: Ravinay Bhindi; Olli A Kajander; Sanjit S Jolly; Saleem Kassam; Shahar Lavi; Kari Niemelä; Anthony Fung; Asim N Cheema; Brandi Meeks; Dimitrios Alexopoulos; Viktor Kočka; Warren J Cantor; Timo P Kaivosoja; Olga Shestakovska; Peggy Gao; Goran Stankovic; Vladimír Džavík; Tej Sheth Journal: Eur Heart J Date: 2015-05-20 Impact factor: 29.983
Authors: Giovanni L De Maria; Niket Patel; Mathias Wolfrum; Gregor Fahrni; George Kassimis; Italo Porto; Sam Dawkins; Robin P Choudhury; John C Forfar; Bernard D Prendergast; Keith M Channon; Rajesh K Kharbanda; Hector M Garcia-Garcia; Adrian P Banning Journal: Coron Artery Dis Date: 2017-05 Impact factor: 1.439
Authors: Henry E Speich; Ronit R Furman; Lindsey T Lands; Geoffrey D Moodie; Lisa K Jennings Journal: J Thromb Thrombolysis Date: 2013-07 Impact factor: 2.300
Authors: Francesco Prati; Giulio Guagliumi; Gary S Mintz; Marco Costa; Evelyn Regar; Takashi Akasaka; Peter Barlis; Guillermo J Tearney; Ik-Kyung Jang; Elosia Arbustini; Hiram G Bezerra; Yukio Ozaki; Nico Bruining; Darius Dudek; Maria Radu; Andrejs Erglis; Pascale Motreff; Fernando Alfonso; Kostas Toutouzas; Nieves Gonzalo; Corrado Tamburino; Tom Adriaenssens; Fausto Pinto; Patrick W J Serruys; Carlo Di Mario Journal: Eur Heart J Date: 2012-05-31 Impact factor: 29.983